ZA919401B - Drug material suitable for micronisation - Google Patents

Drug material suitable for micronisation

Info

Publication number: ZA919401B
Authority: ZA; South Africa
Prior art keywords: salt; micronisation; hydroxy; hydroxynaphthoate; material suitable
Prior art date: 1990-11-29

Application number

ZA919401A

Other languages

English (en)

Inventor

Steven Frederick Beach

Frederick Beach Steven

David William Stuart Latham

William Stuart Latham David

Tony Gordon Roberts

Gordon Roberts Tony

Colin Brian Sidgwick

Brian Sidgwick Colin

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-11-29

Filing date

1991-11-28

Publication date

1992-07-29

1991-11-28 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1992-07-29 Publication of ZA919401B publication Critical patent/ZA919401B/xx

Links

239000003814 drug Substances 0.000 title 1
229940079593 drug Drugs 0.000 title 1
239000000463 material Substances 0.000 title 1
UPHOPMSGKZNELG-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carboxylic acid Chemical class C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 UPHOPMSGKZNELG-UHFFFAOYSA-N 0.000 abstract 1
SWPCURCTHNTSKL-UHFFFAOYSA-N C1=CC=CC2=C(O)C(C(=O)O)=CC=C21.C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 Chemical compound C1=CC=CC2=C(O)C(C(=O)O)=CC=C21.C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 SWPCURCTHNTSKL-UHFFFAOYSA-N 0.000 abstract 1
239000002152 aqueous-organic solution Substances 0.000 abstract 1
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
239000013081 microcrystal Substances 0.000 abstract 1
239000003960 organic solvent Substances 0.000 abstract 1
239000002245 particle Substances 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
238000010791 quenching Methods 0.000 abstract 1
230000000171 quenching effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
- C07C217/10—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Oncology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Polyesters Or Polycarbonates (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Fats And Perfumes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)

ZA919401A 1990-11-29 1991-11-28 Drug material suitable for micronisation ZA919401B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB909026005A GB9026005D0 (en)	1990-11-29	1990-11-29	Drug material suitable for micronisation

Publications (1)

Publication Number	Publication Date
ZA919401B true ZA919401B (en)	1992-07-29

Family

ID=10686212

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA919401A ZA919401B (en)	1990-11-29	1991-11-28	Drug material suitable for micronisation

Country Status (27)

Country	Link
US (1)	US5380922A (da)
EP (2)	EP0639176B1 (da)
JP (1)	JP3375626B2 (da)
KR (1)	KR100192196B1 (da)
AT (1)	ATE144244T1 (da)
AU (1)	AU644505B2 (da)
BG (1)	BG61340B1 (da)
CA (1)	CA2099586C (da)
CY (1)	CY2009A (da)
CZ (1)	CZ282996B6 (da)
DE (1)	DE69122780T2 (da)
DK (1)	DK0639176T3 (da)
ES (1)	ES2093812T3 (da)
FI (2)	FI118155B (da)
GB (1)	GB9026005D0 (da)
GR (1)	GR3022088T3 (da)
HK (1)	HK78997A (da)
HU (1)	HU218205B (da)
IE (1)	IE914146A1 (da)
OA (2)	OA09861A (da)
PL (2)	PL169722B1 (da)
RU (2)	RU2116293C1 (da)
SG (1)	SG49741A1 (da)
SK (1)	SK281095B6 (da)
TW (1)	TW309425B (da)
WO (1)	WO1992009557A1 (da)
ZA (1)	ZA919401B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9026005D0 (en) *	1990-11-29	1991-01-16	Glaxo Group Ltd	Drug material suitable for micronisation
WO1993016031A1 (en) *	1992-02-11	1993-08-19	Glaxo Group Limited	Benzenedimethanol derivative suitable for micronisation
US6254882B1 (en)	1997-09-16	2001-07-03	Sepracor Inc.	Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol
ES2193069T3 (es)	1999-04-14	2003-11-01	Glaxo Group Ltd	Formulacion farmaceutica en aerosol.
WO2002026239A1 (en)	2000-09-26	2002-04-04	Temple University Of The Commonwealth System Of Higher Education	Analgesic and glucosamine compositions
EP2127641A1 (en)	2008-05-26	2009-12-02	Inke, S.A.	Micronisable form of salmeterol xinafoate
KR101100614B1 (ko)	2010-09-20	2011-12-29	한국수력원자력 주식회사	농축폐액 건조물의 펠렛화 장치 및 방법과 이를 이용한 유리조성개발 방법
WO2016142582A1 (en)	2015-03-11	2016-09-15	Fermion Oy	Process for the preparation of crystalline salmeterol and its xinafoate salt

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZW6584A1 (en) *	1983-04-18	1985-04-17	Glaxo Group Ltd	Phenethanolamine derivatives
GB9026005D0 (en) *	1990-11-29	1991-01-16	Glaxo Group Ltd	Drug material suitable for micronisation

1990
- 1990-11-29 GB GB909026005A patent/GB9026005D0/en active Pending
1991
- 1991-11-28 SK SK545-93A patent/SK281095B6/sk not_active IP Right Cessation
- 1991-11-28 PL PL91308211A patent/PL169722B1/pl unknown
- 1991-11-28 WO PCT/GB1991/002108 patent/WO1992009557A1/en not_active Ceased
- 1991-11-28 SG SG1996004594A patent/SG49741A1/en unknown
- 1991-11-28 JP JP50047092A patent/JP3375626B2/ja not_active Expired - Lifetime
- 1991-11-28 CA CA002099586A patent/CA2099586C/en not_active Expired - Lifetime
- 1991-11-28 RU RU93040704A patent/RU2116293C1/ru active
- 1991-11-28 IE IE414691A patent/IE914146A1/en not_active IP Right Cessation
- 1991-11-28 CZ CS931019A patent/CZ282996B6/cs not_active IP Right Cessation
- 1991-11-28 DE DE69122780T patent/DE69122780T2/de not_active Expired - Lifetime
- 1991-11-28 HU HU9301568A patent/HU218205B/hu unknown
- 1991-11-28 EP EP92900167A patent/EP0639176B1/en not_active Expired - Lifetime
- 1991-11-28 PL PL91299352A patent/PL167976B1/pl unknown
- 1991-11-28 ZA ZA919401A patent/ZA919401B/xx unknown
- 1991-11-28 ES ES92900167T patent/ES2093812T3/es not_active Expired - Lifetime
- 1991-11-28 AT AT92900167T patent/ATE144244T1/de not_active IP Right Cessation
- 1991-11-28 DK DK92900167.5T patent/DK0639176T3/da active
- 1991-11-28 RU RU97121416/04A patent/RU2197475C2/ru active
- 1991-11-28 AU AU90402/91A patent/AU644505B2/en not_active Ceased
1992
- 1992-05-21 EP EP92304635A patent/EP0571669B1/en not_active Expired - Lifetime
- 1992-05-29 TW TW081104199A patent/TW309425B/zh active
1993
- 1993-05-14 OA OA60370A patent/OA09861A/en unknown
- 1993-05-14 US US08/050,298 patent/US5380922A/en not_active Expired - Lifetime
- 1993-05-25 BG BG97767A patent/BG61340B1/bg unknown
- 1993-05-27 KR KR1019930701589A patent/KR100192196B1/ko not_active Expired - Lifetime
- 1993-05-27 FI FI932422A patent/FI118155B/fi not_active IP Right Cessation
- 1993-09-24 OA OA60416A patent/OA10024A/en unknown
1996
- 1996-12-18 GR GR960403534T patent/GR3022088T3/el unknown
1997
- 1997-06-12 HK HK78997A patent/HK78997A/en not_active IP Right Cessation
1998
- 1998-02-20 CY CY200998A patent/CY2009A/xx unknown
- 1998-09-28 FI FI982081A patent/FI118203B/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69122780T2 (de)	1997-02-20
EP0571669A1 (en)	1993-12-01
CA2099586A1 (en)	1992-05-30
AU9040291A (en)	1992-06-25
WO1992009557A1 (en)	1992-06-11
EP0639176B1 (en)	1996-10-16
FI982081L (fi)	1998-09-28
KR100192196B1 (en)	1999-06-15
FI932422A0 (fi)	1993-05-27
FI118203B (fi)	2007-08-31
GR3022088T3 (en)	1997-03-31
JP3375626B2 (ja)	2003-02-10
PL169722B1 (pl)	1996-08-30
FI118155B (fi)	2007-07-31
SK281095B6 (sk)	2000-11-07
EP0571669B1 (en)	1996-03-06
GB9026005D0 (en)	1991-01-16
HU218205B (hu)	2000-06-28
HK78997A (en)	1997-06-20
BG61340B1 (en)	1997-06-30
DE69122780D1 (de)	1996-11-21
CZ101993A3 (en)	1994-01-19
ES2093812T3 (es)	1997-01-01
JPH06503082A (ja)	1994-04-07
IE914146A1 (en)	1992-06-03
OA10024A (en)	1996-10-14
SK54593A3 (en)	1993-10-06
ATE144244T1 (de)	1996-11-15
AU644505B2 (en)	1993-12-09
HU9301568D0 (en)	1993-09-28
RU2116293C1 (ru)	1998-07-27
CA2099586C (en)	2002-06-25
TW309425B (da)	1997-07-01
FI932422L (fi)	1993-05-27
BG97767A (bg)	1994-12-02
HUT64219A (en)	1993-12-28
CY2009A (en)	1998-02-20
SG49741A1 (en)	1998-06-15
PL167976B1 (pl)	1995-12-30
RU2197475C2 (ru)	2003-01-27
EP0639176A1 (en)	1995-02-22
OA09861A (en)	1994-08-15
DK0639176T3 (da)	1996-12-23
FI982081A0 (fi)	1998-09-28
US5380922A (en)	1995-01-10
CZ282996B6 (cs)	1997-12-17

Publication	Publication Date	Title
IL111709A0 (en)	1995-01-24	Sustained release compositions and a method of preparing pharmaceutical compositions
GB9026005D0 (en)	1991-01-16	Drug material suitable for micronisation
CA2041378A1 (en)	1991-10-29	Granulated preparations and method of producing the same
HU9402267D0 (en)	1994-11-28	Elevated temperature dimensionally stable polyester with low gas permeability
RU93040704A (ru)	1996-06-20	1-гидрокси-2-нафталинкарбоксилатная соль 4-гидрокси-альфа-[[[6-(4-фенилбутокси)гексил]амино]метил]-1,3-бензолдиметанола в форме сферических сращений микрокристаллов, способ ее измельчения, способ ее получения, применение гидроксинафтоата для получения измельченной гидроксинафтоатной соли
JPS6413004A (en)	1989-01-17	Sustained release ferrous sulfate
MY108410A (en)	1996-09-30	Drug material suitable for micronisation.
GR3020622T3 (en)	1996-10-31	Method to produce pellets containing an ephedrine derivative
GR861872B (en)	1986-11-24	Pharmaceutical preparation with controlled and slowly active substance release and method for preparing it
Kenis et al.	1988	Optimum Control of Cooling Kinetics of the Solid Cylinder in a Sprayer
Marinskii et al.	1988	Examination of the Effect of Working Parameters on the Temperature and Energy Parameters of Electroslag Crucible Melting
李顺朴 et al.	1995	Effects of unsolvable impurities on solidification of nonfaceted-faceted eutectic alloys
Schillings et al.	1999	Transparent model systems
Ermolenko	1985	Induced Spin-Orientation Transitions in the Compound TbCo sub 5. 1
Harada	1986	Powder Forming